All tenders
75N93024C00069
CUTTING EDGE TECHNOLOGIES WILL BE USED TO BOTH DISCOVER AND CHARACTERIZE HUMAN B CELL EPITOPES ON BACTERIAL SURFACE ANTIGENS KNOWN TO BE INVOLVED IN IMMUNITY TO B. BURGDORERI INFECTION.
National Institutes of Health · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedOtherFederal
Basic information
- Reference number
- 75N93024C00069
- Issuing organization
- National Institutes of Health · Find award history →
- Government level
- Federal
- Solicitation type
- Other
- Title
- CUTTING EDGE TECHNOLOGIES WILL BE USED TO BOTH DISCOVER AND CHARACTERIZE HUMAN B CELL EPITOPES ON BACTERIAL SURFACE ANTIGENS KNOWN TO BE INVOLVED IN IMMUNITY TO B. BURGDORERI INFECTION.
- Source
- USASpending (Federal)
- Source ID
- usa-75N93024C00069
Details
- Location
- United States
Description
CUTTING EDGE TECHNOLOGIES WILL BE USED TO BOTH DISCOVER AND CHARACTERIZE HUMAN B CELL EPITOPES ON BACTERIAL SURFACE ANTIGENS KNOWN TO BE INVOLVED IN IMMUNITY TO B. BURGDORERI INFECTION. Awarded to: HEALTH RESEARCH, INC. Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2024/09/16 12:00:00 AM UTC
- Closing date
- 2027/09/15 12:00:00 AM UTC
Estimated value
$5.9M USD
Classification
Normalized category
Other